Hayes ME - Search Results

1

Development of ligand-targeted liposomes for cancer therapy.

Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, Benz CC, Marks JD, Drummond DC. Noble CO, et al. Among authors: hayes me. Expert Opin Ther Targets. 2004 Aug;8(4):335-53. doi: 10.1517/14728222.8.4.335. Expert Opin Ther Targets. 2004. PMID: 15268628 Review.

2

Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery.

Hayes ME, Drummond DC, Kirpotin DB, Zheng WW, Noble CO, Park JW, Marks JD, Benz CC, Hong K. Hayes ME, et al. Gene Ther. 2006 Apr;13(7):646-51. doi: 10.1038/sj.gt.3302699. Gene Ther. 2006. PMID: 16341056

3

Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases.

Hayes ME, Drummond DC, Hong K, Park JW, Marks JD, Kirpotin DB. Hayes ME, et al. Biochim Biophys Acta. 2006 Apr;1758(4):429-42. doi: 10.1016/j.bbamem.2006.03.020. Epub 2006 Apr 17. Biochim Biophys Acta. 2006. PMID: 16678786 Free article.

4

Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation.

Hayes ME, Drummond DC, Hong K, Zheng WW, Khorosheva VA, Cohen JA, C O N 4th, Park JW, Marks JD, Benz CC, Kirpotin DB. Hayes ME, et al. Mol Pharm. 2006 Nov-Dec;3(6):726-36. doi: 10.1021/mp060040v. Mol Pharm. 2006. PMID: 17140260

5

Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

Zhou Y, Drummond DC, Zou H, Hayes ME, Adams GP, Kirpotin DB, Marks JD. Zhou Y, et al. Among authors: hayes me. J Mol Biol. 2007 Aug 24;371(4):934-47. doi: 10.1016/j.jmb.2007.05.011. Epub 2007 May 10. J Mol Biol. 2007. PMID: 17602702 Free PMC article.

6

Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, Benz CC, Marks JD, Liu B. Roth A, et al. Among authors: hayes me. Mol Cancer Ther. 2007 Oct;6(10):2737-46. doi: 10.1158/1535-7163.MCT-07-0140. Mol Cancer Ther. 2007. PMID: 17938267

7

Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.

Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Drummond DC, et al. Among authors: hayes me. J Pharm Sci. 2008 Nov;97(11):4696-740. doi: 10.1002/jps.21358. J Pharm Sci. 2008. PMID: 18351638 Review.

8

Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine.

Drummond DC, Noble CO, Guo Z, Hayes ME, Park JW, Ou CJ, Tseng YL, Hong K, Kirpotin DB. Drummond DC, et al. Among authors: hayes me. J Pharmacol Exp Ther. 2009 Jan;328(1):321-30. doi: 10.1124/jpet.108.141200. Epub 2008 Oct 23. J Pharmacol Exp Ther. 2009. PMID: 18948499 Free PMC article.

9

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine.

Noble CO, Guo Z, Hayes ME, Marks JD, Park JW, Benz CC, Kirpotin DB, Drummond DC. Noble CO, et al. Among authors: hayes me. Cancer Chemother Pharmacol. 2009 Sep;64(4):741-51. doi: 10.1007/s00280-008-0923-3. Epub 2009 Jan 30. Cancer Chemother Pharmacol. 2009. PMID: 19184019 Free PMC article.

10

Development of a highly stable and targetable nanoliposomal formulation of topotecan.

Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, Gabriel BS, Hann B, Liu B, Park JW, Hong K, Benz CC, Marks JD, Kirpotin DB. Drummond DC, et al. Among authors: hayes me. J Control Release. 2010 Jan 4;141(1):13-21. doi: 10.1016/j.jconrel.2009.08.006. Epub 2009 Aug 15. J Control Release. 2010. PMID: 19686789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters